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Background: ALS is a neurodegenerative disease of the entire motor system that most
frequently ends with respiratory arrest in few years. Its diagnosis and the rapid progres-
sion of the motor dysfunctions produce a continued emotional impact. Studies on this
impact are helpful to plan adequate psychotherapeutic strategies. Objective: To assess
and analyze: First: How the patients with ALS perceive their emotional health. Second:The
emotional impact of their physical disabilities. Third: The physical disabilities with highest
emotional impact. Fourth:The feelings with highest emotional impact. Methods: Up to 110
Spanish patients with ALS were assessed less than 1 year from diagnosis, then twice more
at 6 month intervals, using the ALS Quality of Life Assessment Questionnaire (ALSAQ-40)
validated for use in Spanish. Descriptive analysis and correlation between variables were
obtained. Results: Worries about the future, of lack of freedom, and of being a burden
were prevalent feelings. On average depression was felt only “sometimes.” Only 25% of
the variations in the emotional state were explained by changes in the physical state at first
evaluation, and 16% at the last one. Emotional functioning correlated significantly with the
physical disabilities at first and second evaluation, less so at third. Communication disabili-
ties always had the highest impact. Depression at first evaluation and hopelessness at the
next two evaluations had the highest emotional impact. Hopelessness did not correlate
with any physical disability at the third evaluation. On the whole, emotional dysfunction
was self perceived as intermediate (between none and worst), and remained stable at
1 year follow up, in both bulbar and spinal onset patients. Conclusions: Physical dysfunc-
tions per se have a limited role in patients´ emotional distress. Communication disabilities,
as well as feelings of depression at early stages of illness, and of hopelessness later on,
had the most impact.This requires their careful therapeutic attention. On average, Spanish
patients with ALS cope with their disease, overcoming depression, which is not felt often,
and with just mid levels of emotional dysfunction.
Keywords: amyotrophic lateral sclerosis, ALS, quality of life, emotional functioning, ALSAQ-40, self evaluation,
depression, hopelessness
INTRODUCTION
ALS causes a progressive and generally rapid degeneration of the
entire motor neuron system and, as a result of the subsequent
muscle denervation, atrophy and weakness of the skeletal muscles,
including limbs, bulbar, and respiratory muscles. Mean survival is
about 3.5 years. 50% of patients may survive 3 years, 20% 5 years,
and less than 10% 10 years. Minor cognitive deficits have been doc-
umented in up to 50% of patients, but 5–13% of patients may also
develop frontotemporal dementia (FTD). ALS and FTD may have
genetic overlapping (Mora Pardina, 2011). At present, ALS does
not have a cure, or even a treatment that patients might perceive as
clinically significant. Patients experience the progression of their
disease as their physical disabilities progress and extend relent-
less. People suffering from ALS go through a tremendous amount
of continuous emotional distress, right after a shocking diagno-
sis. The rapid decline in skeletal muscle strength causes physical
dependence up to for the basic activities of daily life (ADL), which
entails complex and mixed emotional reactions. The disease affects
not only the patient but also their caregivers and family mem-
bers, all of whom face hard emotional challenges that interrelate
with those of the patient (Salas and Lacasta, 1999; Pagnini et al.,
2010a,b).
We often observe that severe physical deficits do not systemati-
cally correlate with increased levels of depression, self perception
of poor quality of life (QoL), or high emotional distress (Salas and
Lacasta, 1999), as others have also observed (Pagnini, 2012). More-
over, the impact the disease has on emotional well-being differs
significantly between individuals, and the psychological reaction
of the patients to their disease and their ability to cope has an
effect on the disease’s evolution (Chiò et al., 2004; Roach et al.,
2009; Montel et al., 2012). Therefore, the traditional assumption
of a tight correlation between rapidly progressive severe physical
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disabilities and emotional distress ought to be reconsidered. To
study the relationship between the different physical disabilities
caused by the disease and the emotional impact they may produce
for the patient may contribute to better understanding and treat-
ment of the emotional distress that ALS patients and their families
endure. We understand that the way patients cope with their dis-
ease may be influenced by their cultural background; this is the
first study to look at a Spanish population.
OBJECTIVE
To assess and analyze, at different times during their disease:
First: How the patients with ALS perceive their own emotional
health.
Second: The emotional impact of each one of their physical
disabilities.
Third: The physical disabilities with the highest emotional
impact.
Fourth: The feelings with the highest emotional impact.
MATERIALS AND METHODS
MEASURING TOOL
We considered the ALS Assessment Questionnaire (ALSAQ-40) to
be the most appropriate measuring tool for our objectives. The
ALSAQ-40 is a specific state of health self appraisal questionnaire
for ALS patients that looks at physical and emotional areas con-
sidered important by patients (Jenkinson et al., 1999; Epton et al.,
2009). The ALSQ-40 has been validated for use in the Spanish
language (Salas et al., 2008).
The ALSAQ-40 consists of 40 questions assessing four physi-
cal and one emotional area or dimension as self perceived by the
patient. These are Physical Mobility (MOB), Independence/ADL
(ADL), Eating and Drinking (EAT), Communication (COM),
and Emotional Functioning (EMO). The first four dimensions
assess physical deficiencies or disabilities that occur along with
the disease. The fifth area evaluates the way that the patient deals
emotionally with the disease. Each question or item is scored 0 to 4
according to the frequency of the symptom or feeling (never, rarely,
sometimes, frequently, always). From the direct scores it is possible
to obtain for each dimension an index ranging from 0 (best state of
health) to 100 (worst state) which allows comparisons to be made
between dimensions or over time. This ALS specific QoL measur-
ing tool has demonstrated high validity, consistency, and reliability
and appears sensitive to changes that have an impact on the over-
all status of patients (Jenkinson et al., 1999; Epton et al., 2009). It
has been validated in different languages (Yamaguchi et al., 2004;
Maessen et al., 2007; Salas et al., 2008; Palmieri et al., 2010; Pavan
et al., 2010).
PATIENT SAMPLE AND METHODS
A total of 231 Spanish ALS patients were originally included in
a 4-year long study. All were diagnosed with probable or definite
ALS according to the El Escorial diagnostic criteria. None had
clinical evidence of FTD, and all were receiving treatment with
riluzol, the only approved ALS drug. They were living in differ-
ent regions of Spain but they attended the ALS clinic at differing
intervals. Of the total, only 110 patients whose first assessment was
done no later than 12 months after diagnosis have been included
in this study, in order to ensure a homogenous sample in terms
of disease timeline. The evaluation of patients was longitudinal.
Each patient filled out the questionnaire at three different times
at 6 month intervals. Responses were always written or dictated by
the patient. The questionnaire was first mailed accompanied by a
request and an explanatory letter, and it was returned in clinic or
by mail. The second and third evaluations were done in clinic or
at home if the patient could not attend the clinic, and then mailed
to us. The questionnaire could be completed in 10 min.
STATISTICAL ANALYSIS
Independent or explanatory variables were age, gender, site of
onset (bulbar vs. spinal), time from onset of symptoms, time from
diagnosis, and 30 functional variables, questions or items taken
from the physical areas of the ALSAQ-40: Items 1–10 (MOB), 11–
20 (ADL), 21–23 (EAT), and 24–30 (COM). Dependent variables
were the 10 items, 31–40 (EMO) from the emotional dimension.
These are:
1. I have felt lonely
2. I have been bored
3. I have felt embarrassed in social situations
4. I have felt hopeless about the future
5. I have worried that I am a burden to other people
6. I have wondered why I keep going
7. I have felt angry because of the disease
8. I have felt depressed
9. I worried about how the disease will affect me in the future
10. I have felt as if I have no freedom
The statistical analyses were descriptive, of correlation (regres-
sion analysis, Pearson’s correlation), and of mean differences (t -
test for independent samples), using SSPS v.15.0 for Windows,
Microsoft Excel, and EPI INFO 2000.
RESULTS
DEMOGRAPHY
The sample size was 110 patients, 50 women and 60 men. 70
patients had spinal onset, 40 had bulbar onset (Table 1). Mean
age at the first evaluation of 59± 14 years. Mean time between
diagnosis and first assessment was 5.8± 4.0 months. The sec-
ond evaluation was completed 5.7± 1.5 months after the first
one by 76 patients (69.1%). The third assessment was filled out
6.5± 1.0 months later by 52 patients (47.3%).
SELF PERCEPTION OF EMOTIONAL HEALTH
In spite of increasing scores in the physical areas (MOB, ADL, EAT,
COM) as the disease progresses, the emotional area (EMO) scores
did not significantly increase (t -test for independent samples;
Table 1 | Sample distribution by gender and site of onset.
Bulbar Spinal Total
Women 24 (21.8%) 26 (23.7%) 50 (45.5%)
Men 16 (14.6%) 44 (39.9%) 60 (54.5%)
Total 40 (36.4%) 70 (63.6%) 110 (100%)
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Table 2). During the three evaluations, there are no significant dif-
ferences in EMO between patients with bulbar and spinal onset,
in spite of them having significant differences in physical func-
tions: higher MOB scores in spinal onset patients, and higher EAT
and COM scores in bulbar onset patients, as expected (Table 2).
During the study period, mean EMO scores remain at around
mid level, between best and worst. There are no significant differ-
ences in EMO scores between the first and third evaluations (1.74
points), and even less between the second and third evaluations
(0.33 points; Figure 1).
At the first evaluation, less than 12 months after diagnosis, the
feelings most often felt (that is, a score higher than 2: “sometimes”)
were worries about how the disease will affect the patient in the
future (2.77), and feelings of being a burden to others (2.45),
of lack of freedom (2.24), and of hopelessness (2.21). Anger at
the disease (2.00) and depression (1.94) came after, but scored
higher in patients who had been diagnosed less than 6 months
ago (Table 3). At the second evaluation, about 6 months later, the
feelings most often felt remain the same: worries about the future
(2.66), lack of freedom (2.64), being a burden (2.53), hopelessness
(2.33), and anger (2.22). Depression remained lower than 2 (1.91).
At the third evaluation, 1 year after the first one, feelings of lack
of freedom (2.98), worries about the future (2.73), and of being
a burden (2.60) got close to a score of 3: “frequently.” Hopeless-
ness (2.21), anger (2.06), and depression (2.02) maintained similar
scores to the first evaluation (Table 3).
EMOTIONAL IMPACT OF PHYSICAL DISABILITIES
To calculate how much the physical disability may be directly
responsible for the emotional distress experienced by the patients,
Table 2 | Mean and SD for each area in bulbar and spinal onset.
MOB ADL EAT COM EMO
Bulbar Spinal Bulbar Spinal Bulbar Spinal Bulbar Spinal Bulbar Spinal
Maximun score 40 40 40 40 12 12 28 28 40 40
First evaluation 14.5±11.4 19.8±9.7 18.1±12.9 20.6±11.6 8.1±3.6 1.9±2.9 20.6±7.5 4.6±6.1 19.7±13.1 17.4±8.4
Second evaluation 19.3±13.1 25.1±11.9 23.9±13.3 25.4±11.6 9.4±3.4 2.2±3.5 23.5±6.5 8.8±9.3 21.0±9.7 19.1±10.5
Third evaluation 21.6±12.9 29.4±10.9 24.9±12.7 30.7±11.3 9.6±2.4 4.3±4.4 23.0±5.6 11.6±10.2 19.3±9.4 20.3±11.7
FIGURE 1 | Evolution of EMO along the three evaluations for the total sample.
Table 3 | Mean scores and SD of EMO items at the three evaluations.
EMO items* First evaluation Second evaluation Third evaluation
1. I have felt lonely 0.98±1.3 1.16±1.5 1.10±1.5
2. I have felt bored 1.30±1.3 1.64±1.5 1.67±1.4
3. I have felt embarrassed in social situations 1.07±1.3 1.10±1.4 1.15±1.3
4. I have felt hopelessness about the future 2.21±1.2 2.33±1.4 2.21±1.5
5. I have worried about being a burden to other people 2.45±1.2 2.53±1.2 2.60±1.4
6. I have wondered why I keep going 1.30±1.4 1.49±1.5 1.56±1.5
7. I have felt angry because of the disease 2.00±1.4 2.22±1.4 2.06±1.5
8. I have felt depressed 1.94±1.2 1.91±1.3 2.02±1.4
9. I have worried about how the disease will affect me in the future 2.77±1.0 2.66±1.3 2.73±1.4
10. I have felt as if I have no freedom 2.24±1.4 2.64±1.5 2.98±1.3
*Items are scored as: Never=0, Rarely=1, Some times=2, Frequently=3, Always=4.
Bold indicates higher values that are most significant.
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we carried out a dispersion diagram and calculated its linear
regression. We used the EMO score as dependent variable and the
sum of the scores of the physical areas (MOB, ADL, EAT, COM) as
independent variables. The null hypothesis establishes that there
is no relationship whatsoever between the two variables. To cal-
culate the linear regression with 5% error and 95% confidence
interval, we obtained y = 8.298+ 0.191x with a correlation coeffi-
cient R= 0.51 and a determination coefficient of R2= 0.25. This
indicates that only 25% of the variations that occur in the emo-
tional state are explained by the changes in the physical state. The
same analysis at the last evaluation produced the linear regres-
sion equation y = 7.80+ 0.16x, with a correlation coefficient of
R= 0.42 and a determination coefficient of R2= 16. This shows
an even smaller relationship between emotional and physical func-
tions: only 16% of the variations that occur in the emotional
state at the third evaluation, when patients experience more severe
disabilities, are explained by the variations in the physical state
(Figure 2).
PHYSICAL DISABILITIES WITH HIGHEST EMOTIONAL IMPACT
At the first evaluation there were significant correlations between
EMO and COM, MOB and EAT (p< 0.01; bilateral, Pearson’s cor-
relation) in that order, and less significantly with ADL (p< 0.05;
Table 4). At the second assessment there were significant correla-
tions with all four physical areas (p< 0.01), the highest seen with
COM, then with ADL (Table 5). At the third evaluation, the high-
est correlation continued being with COM (p< 0.01), and less so
with MOB and EAT (p< 0.05; Table 6).
FEELINGS WITH HIGHEST EMOTIONAL IMPACT
Since physical dysfunctions were only partially responsible for the
emotional impact, with an impact ranging from 25% at first eval-
uation to 16% at last evaluation, as shown in section 2, we assessed
correlations between the different emotional states in EMO and
the total EMO. To assess which emotions are elicited by the differ-
ent physical disabilities, we calculated correlations between each
FIGURE 2 | Dispersion graph for emotional functioning and total
combined physical functions at the third evaluation.
EMO item and MOB, ADL, EAT, and COM (Tables 7–9). At
the first evaluation all EMO items correlated highly with total
EMO (p< 0.01 bilateral). The highest were items 8 on depression
(Pearson r = 0.81), 7 on anger (r = 0.75), and 6 on keep going
(r = 0.74). Item 8 on depression correlated highly (p< 0.01) with
disabilities in MOB (r = 0.27) and COM (r = 2.5), and less so
(p< 0.05) with ADL and EAT. All of them significantly less than
with EMO (r = 0.81). Item 7 on anger correlated highly with MOB,
COM, and ADL (p< 0.01) and less so with EAT (p< 0.05). Item 6
on keep going correlated highly with EAT, COM, and MOB. In all
cases, the correlations were at much lower levels than with EMO
(Table 7).
At the second assessment all EMO items kept a high cor-
relation (p< 0.01) with total EMO. The feelings with highest
correlations were items 4 on hopelessness (r = 0.85), 8 on depres-
sion (r = 0.84), and 10 on lack of freedom (r = 0.78). Item 4 on
hopelessness and 8 on depression correlated highly with COM
(r = 0.32) and less so with the other physical areas. Item 10 on
lack of freedom correlated highly with COM, MOB, and ADL,
and less so with EAT. All EMO items correlated highly with COM,
except items 5 on being a burden and 9 on worries about future
(Table 8).
At the third evaluation every EMO item maintained its high cor-
relation with total EMO. The feelings with the highest correlations
were items 4 on hopelessness (r = 0.91),6 on keep going (r = 0.84),
2 on feeling bored (r = 0.83), and 8 on depression (r = 0.80). Item
Table 4 | Correlations between areas at the first evaluation.
ADL EAT COM EMO
MOB 0.400** 0.001 −0.046 0.360**
ADL 1 0.095 0.017 0.242*
EAT 1 0.856** 0.307**
COM 1 0.398**
*p<0.05 bilateral; **p<0.01 bilateral.
Table 5 | Correlation between areas at the second evaluation.
ADL EAT COM EMO
MOB 0.552** 0.022 0.165 0.331**
ADL 0.203 0.317** 0.346**
EAT 1 0.854** 0.342**
COM 1 0.444**
*p<0.05 bilateral; **p<0.01 bilateral.
Table 6 | Correlation between areas at the third evaluation.
ADL EAT COM EMO
MOB 0.556** 0.278* 0.300* 0.330*
ADL 1 0.220 0.301* 0.267
EAT 1 0.845** 0.301*
COM 1 0.355**
*p<0.05 bilateral; **p<0.01 bilateral.
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Table 7 | Correlations between EMO items and other areas at the first evaluation.
EMO Items MOB ADL EAT COM EMO
1. I have felt lonely 0.148 0.112 0.386** 0.399** 0.673**
2. I have felt bored 0.217* 0.183 0.249** 0.332** 0.625**
3. I have felt embarrassed in social situations 0.052 −0.011 0.433** 0.507** 0.540**
4. I have felt hopelessness about the future 0.294** 0.144 −0.049 0.017 0.670**
5. I have worried about being a burden to other people 0.265** 0.241* 0.087 0.133 0.702**
6. I have wondered why I keep going 0.274** 0.163 0.306** 0.290** 0.740**
7. I have felt angry because of the disease 0.297** 0.272** 0.227* 0.293** 0.751**
8. I have felt depressed 0.274** 0.214* 0.200* 0.254** 0.812**
9. I have worried about how the disease will affect me in the future 0.198* 0.154 0.054 0.154 0.712**
10. I have felt as if I have no freedom 0.441** 0.197* 0.168 0.309** 0.688**
*p<0.05 bilateral; **p<0.01 bilateral.
Bold indicates higher values that are most significant.
Table 8 | Correlations between EMO items and other areas at the second evaluation.
EMO Items MOB ADL EAT COM EMO
1. I have felt lonely 0.081 0.106 0.416** 0.462** 0.620**
2. I have felt bored 0.253* 0.406** 0.351** 0.408** 0.757**
3. I have felt embarrassed in social situations 0.170 0.125 0.337** 0.371** 0.561**
4. I have felt hopelessness about the future 0.271* 0.260* 0.241* 0.324** 0.847**
5. I have worried about being a burden to other people 0.216 0.289* 0.085 0.123 0.704**
6. I have wondered why I keep going 0.290* 0.252* 0.235* 0.295** 0.766**
7. I have felt angry because of the disease 0.290* 0.295** 0.223 0.334** 0.769**
8. I have felt depressed 0.254* 0.252* 0.181 0.326** 0.844**
9. I have worried about how the disease will affect me in the future 0.088 0.066 0.118 0.162 0.658**
10. I have felt as if I have no freedom 0.477** 0.450** 0.256* 0.380** 0.783**
**p<0.01 bilateral; *p<0.05 bilateral.
Bold indicates higher values that are most significant.
Table 9 | Correlations between EM items and other areas at the third evaluation.
EMO Items MOB ADL EAT COM EM
1. I have felt lonely 0.254 0.011 0.149 0.145 0.682**
2. I have felt bored 0.319* 0.163 0.364** 0.298* 0.826**
3. I have felt embarrassed in social situations 0.164 0.174 0.255 0.317* 0.634**
4. I have felt hopelessness about the future 0.238 0.220 0.076 0.152 0.913**
5. I have worried about being a burden to other people 0.234 0.286* 0.138 0.219 0.698**
6. I have wondered why I keep going 0.193 0.166 0.143 0.209 0.836**
7. I have felt angry because of the disease 0.233 0.181 0.245 0.152 0.777**
8. I have felt depressed 0.370** 0.313* 0.339* 0.494** 0.801**
9. I have worried about how the disease will affect me in the future 0.121 0.186 0.205 0.299* 0.762**
10. I have felt as if I have no freedom 0.425** 0.377** 0.433** 0.488** 0.764**
**p<0.01 bilateral; *p<0.05 bilateral.
Bold indicates higher values that are most significant.
4 on hopelessness and item 6 on keep going did not correlate
with any of the physical disabilities. Item 2 on boredom corre-
lated highly with EAT and less so with MOB and COM. Item 8 on
depression correlated highly with COM and MOB and less so with
ADL. Item 10 on lack of freedom was highly correlated (p< 0.01)
with the five areas (Table 9).
DISCUSSION
This study shows that as the physical deterioration of the patients
with ALS increased, the self perception of the emotional distress
remained more or less stable, and this happened in both spinal
and bulbar onset patients, who have different timings of their
physical disabilities. Emotional distress was felt, on average, as
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intermediate between none or worst. At the first evaluation the
most frequent worries, felt more than sometimes but less than
frequently, were those about the future, of losing autonomy, of
being a burden, and then of despair. Less frequently felt, just some-
times, were depression and anger, which were more frequently felt
nearer the time of diagnosis. This pattern continued at the sec-
ond evaluation, with a slight increase in loss of freedom and with
depression felt slightly less than sometimes. At the last evaluation,
between 18 and 24 months after diagnosis, the pattern continues
but lack of autonomy is the prevalent feeling followed by fear of
the future and of being a burden, these three feelings got closer
to being felt frequently. Depression remained stable, just being felt
sometimes.
This pattern suggests that, for Spanish patients attending an
ALS unit, the most frequent distressful thoughts are those related
to fear of the future and of loss of autonomy with concerns for
loved ones. Feelings of hopelessness, of depression and anger were
felt less often. This might be explained by the attendance of a
specialized clinic whose professionals try to fight those negative
feelings with constant information on research, clinical trials, and
psychological surveillance. Other explanations could be linked to
the patients´ shared cultural and social background.
All four physical disabilities correlate with EMO, but it is the
COM disability that has the most emotional impact as soon as it
appears. This implies that dedicated care of this disability is impor-
tant since it is a cause of significant distress. On the whole, physical
disabilities accounted for only 25–16% of the emotional distress,
and less so as the disease advances. Other varied psychosocial fac-
tors may contribute to modify the EMO (Pagnini, 2012). However,
each negative feeling tested correlated highly with the global emo-
tional dysfunction. It seems plausible that any psychosocial factor,
such as advanced health care, strong familial, and social support,
spirituality, or an optimistic personality, could influence the EMO
of the patient by changing their patterns of feelings or emotions.
Negative thoughts, not the physical disabilities per se, may account
for an important part of the emotional distress felt by patients.
We have known for a long time that emotional distress does not
depend on the physical damage that one experiences but on the
way that the mind processes the experience (adapted from Epicu-
rus, 300 B.C.: “To humans, the things do not affect us by themselves,
but by the way we interpret them”).
All 10 feelings or emotional states tested correlate strongly with
the global EMO, but each one has a different weight as representa-
tive of the patient’s EMO at different times. Less than 1 year after
diagnosis depression is the feeling with most emotional impact,
followed by anger, although on average they were felt only “some
times.” Both are highly related to the dysfunctions in COM and
MOB. Once most disabilities are present, 18 months after diagno-
sis, feelings of hopelessness reach the same power as depression,
with the COM disabilities contributing most to these feelings. Two
years after diagnosis, most feelings have increased their impact, but
those of hopelessness and of stopping fighting are the most rep-
resentative. Worries about the future and of lack of freedom are
perceived often but produce a lesser impact. Interestingly, except
for lack of freedom, none of the emotional states are related to the
severity of the physical dysfunctions at this stage of the disease. In
this way, they are negative states of mind, not directly related to
the physical disabilities, and so, subject to be treated by dedicated
psychotherapy.
Many studies have tried to determine what is called the QoL
of patients with ALS, and many scales have been created that try
to measure it. QoL may be a confusing concept in this dread-
ful disease, which makes it more difficult to “measure.” The
methodological limitations inherent to this measurement con-
tribute to a wide range of reported results, and statements on
QoL must be considered dependent of the scale used. An excel-
lent review has recently been published (Pagnini, 2012). QoL
has been reported to be negatively correlated to suffering, a
sense of burden, and hopelessness, and positively correlated to
social support (Epton et al., 2009). Its relation with physical
functioning was unclear to some (Ganzini et al., 1999) and it
was more related to psychosocial rather than physical aspects
of life, particularly in those patients with physical disabilities
(Clarke et al., 2001). QoL, as assessed by the patient, has not
been correlated to physical function or strength, but to psycho-
logical and existential factors, as well as to spiritual factors and
support systems (Simmons et al., 2000, 2006). Hopelessness in
ALS has been correlated with suffering and negatively with QoL
(Ganzini et al., 1999). Hope did not correlate with physical and
respiratory functions (Fanos et al., 2008). The real prevalence of
depressive and anxious symptom in ALS is unclear (Norris et al.,
2010; Taylor et al., 2010) although some studies found depres-
sive symptoms common, and severe in 11–15% of the patients
(McLeod and Clarck, 2007). Swallowing and breathing difficulties
have been related to depressive symptoms, however the sever-
ity of the disease as such or its duration were not (Hillemaker
et al., 2004). Most of these studies are in accordance with our
findings.
An evaluation of 28 studies concluded that clinically signif-
icant depression is neither as prevalent nor as severe as might
be expected and that patients are more likely to present with
hopelessness and end-of-life concerns than clinically significant
depression (Averill et al., 2007), this is consistent with our find-
ings. Thirty ALS patients showed good psychosocial adjustment
and subjective QoL, mild depressive symptoms, and no clinically
relevant depression (Lulé et al., 2012). Another study rated QoL
on average as satisfactory and found a moderate positive relation
to physical impairment and a weak negative relation to time since
diagnosis (Kubler et al., 2005). Despite marked deterioration in
the patients’ health, there was no change in mental well-being and
QoL. Psychological well-being appeared more important in main-
taining QoL than physical factors (O’Doherty et al., 2010). Few
changes were observed in the QoL of 35 patients over time (Ols-
son et al., 2010). The general QoL changed little overtime in 60
patients (Robbins et al., 2001). Individual QoL remained stable in
42 patients and was not dependant on physical function but on
family, friends/social life, health, and profession (Neudert et al.,
2004). There was substantial steadiness of QoL in 31 patients over
9 months (Gauthier et al., 2007). No relationship between EMO
and muscle strength or functional ability was found in 30 patients
(Palmieri et al., 2010). Most of these studies are in accordance with
our findings.
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What emerges from our study and others is that for ALS
patients, as a group,physical dysfunction per se is not the main con-
tributor to emotional suffering. Emotional suffering seems more
related to negative feelings linked to the new physical condition.
However, emotional dysfunction, and depression at its paradigm,
do not seem to be exaggerated in spite of severe physical dys-
function and remain somehow stable along most of the disease.
Terminal phases need additional studies. Since we do not agree
with the idea of ALS affecting only nice and suffering-resilient peo-
ple, we understand that ALS patients as a group behave as any other
human group who try to cope with misfortune the best they can. As
in any human disaster the emotional health of each ALS patient is
not completely dependent on his/her physical strength but on the
strength of the coping mechanisms that he/she may build to deal
with the situation These mechanisms may be individual, familial,
social, or spiritual, health care provided or other. It is difficult and
risky to extrapolate results obtained from groups to individual
patients since the individual variables that influence the specific
QoL of each person are so varied. To facilitate the work of the
therapists, our study tries to understand the contribution of spe-
cific negative feelings and worries, and their subsequent emotional
states, to the emotional suffering of the patients throughout their
disease, and which specific physical disabilities are most related to
them. Specific psychotherapeutic interventions should be imple-
mented to help the patient to overcome them. Development of
adequate protocols is needed (Pagnini et al., 2012).
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